Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
Pain Management Market Research Reports
Pain Management Market Research Reports
| Title | published | price | |
|---|---|---|---|
Post-Operative Pain – Pipeline Review, H1 2015By Global Markets Direct "......ages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic develop......" | 23-Jan-2015 | $2000 | |
Therapeutic Class Overview : Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of PainBy MP Advisors "....... Opioids (e.g., morphine, codeine, oxycodone) are currently one of the most potent groups of analgesics used clinically, with prescriptions increasing by 50% over the past 10 years for chronic, non-cancer pain. However, there is clear evidence that ......" | 13-Jan-2015 | $3000 | |
Hyperalgesia – Pipeline Review, H2 2014By Global Markets Direct "......sessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hyperalgesia......" | 24-Dec-2014 | $2000 | |
Post-Operative Pain – Pipeline Review, H2 2014By Global Markets Direct "......ages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic develop......" | 30-Nov-2014 | $2000 | |
Opioids Market Overview to 2023 – Opioids in Emerging MarketsBy CBR Pharma Insights "......eeing controlled medicines due to their high abuse potential. Emphasis on restricting access to controlled drugs is much higher in emerging markets than in developed nations, resulting in a level of consumption that is too low to meet pain-control re......" | 30-Nov-2014 | $2995 | |
Moderate Pain – Pipeline Review, H2 2014By Global Markets Direct "...... assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Moderate ......" | 18-Nov-2014 | $2000 | |
Ocular Pain – Pipeline Review, H2 2014By Global Markets Direct "......sment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ocular Pain and......" | 14-Nov-2014 | $2000 | |
Pain Partnering 2009-2014By Current Partnering "......ty of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pain technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outc......" | 1-Nov-2014 | $1995 | |
Opioids Market Overview to 2023 – Opioids in Western EuropeBy CBR Pharma Insights "......h 20%. Spain had the lowest in terms of both consumption (3.3%) and revenues (2.2%).
Their use for medicinal purposes has been highly controversial for several decades. Although recognized as potent painkillers, potential for misuse is high. As a ......" | 31-Oct-2014 | $2995 | |
Neuropathic Pain – Pipeline Review, H2 2014By Global Markets Direct "......rapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for ......" | 30-Oct-2014 | $2000 | |